CA9 and renal carcinoma: A study utilized a combination of OAVs arming chemokine (C-C motif) ligand5 (CCL5) and IL-12 (Ad5-ZD55-CCL5-IL12) along with CAR-T cells that targeted carbonic anhydrase 9 (CA9) in renal cancer cells.